Novo Nordisk CEO Discusses Trump Deal and Pharma Market

Novo Nordisk CEO Mike Doustdar told the Financial Times that the pharmaceutical industry is only "scratching the surface" of the market, explaining why the company made a deal with Trump last year.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskeDanish2d ago

Mike Doustdar i interview med amerikansk medie: Derfor var aftale med Trump god for os

I et interview med Financial Times fortæller Novo Nordisk-topchef Mike Doustdar, at medicinalbranchen kun »kradser overfladen« af markedet. Blandt andet derfor indgik Novo Nordisk aftale med Trump sidste år, lyder det fra Novo-topchefen.

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk CEO Discusses Trump Deal and Pharma Market

Sources

Mike Doustdar i interview med amerikansk medie: Derfor var aftale med Trump god for os

Related Stories

Philippine Justice Questions Identity of 'SBR' in Flood Control Project

Philippine Government Addresses Supply Chain Concerns

Brian Poe calls for ‘people’s hearing’ on oil crisis, energy reforms

Manila Water Prepares for Summer Heat and High Demand

PERSPECTA